Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04157517
Title A Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics Study
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

lung non-small cell carcinoma

prostate cancer

Advanced Solid Tumor

Therapies

TAK-573

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.